Ranbaxy Launches Cholesterol-Reducing Lipogen In South Africa

Atorvastatin, a cholesterol-reducing medicine is a generic equivalent of the Pfizer’s brand Lipitor, a member of the drug class known as statins. It stabilises plaque and prevents strokes through anti-inflammatory and other mechanisms.

Pharmacia, a Pfizer company, also markets an authorised generic, Aspavor in 10mg, 20mg, 40mg strengths.

Ranbaxy claimed that the launch of Lipogen provides patients with a high quality generic alternative, at an affordable price. Favorable reimbursement terms to encourage generic substitution have also been worked out.

Ranbaxy added that Lipogen is also the first generic in South Africa to carry information in blind friendly Braille format on its packaging.